IMA Group

FASP srl are into development of technological systems for the electric motors manufacturing.

Atop manufacturing of machines and complete lines with the highest technological content for the production of wound stators and rotors of electric motors, developed to guarantee maximum flexibility, reliability and ease of use. Exploiting its strength and capacity to offer tailored solutions with the goal to meet specific customer requests, even the most complex, worldwide.

Inkbit creats a next-generation additive manufacturing platform that combines 3D printing with machine vision. MIT-trained scientists and engineers combines expertise in industrial systems, design software, and material science to identify and seize opportunities for mass-market additive manufacturing.

TMC is a logistics company that provides TMS software and logistics process management services. The company provides technology solutions and consulting services to help shippers optimize networks and also enable shippers to maintain control over the supplier and carrier relationships. The company manages customers around the world via global Control Tower locations in Chicago and United States headquarters, as well as in Amsterdam, Sao Paulo, Shanghai, and Wroclaw. This Control Tower network, supported by the company's technology platform, links the customers to suppliers and supply chain partners. The customers leverage these capabilities to manage the logistics in over 170 countries across all modes of transportation. TMC was founded on 1999 and is headquartered in Chicago, Illinois.

Eurosicma Machines for packaging candies, jellies, gums, chocolates, bars, biscuits, wafers, noodles.

OYSTAR is a privately held company that develops, manufactures, and markets individual machines and complete packaging lines for dairy.

CONTINUUS Pharmaceuticals works with pharmaceutical and generic companies under a Build-Own-Operate model. They design, build, and run the manufacturing process directly at the client site. This novel business model provides its clients with an exceptional, ”one-shop solution” for their entire development and manufacturing cycle. CONTINUUS Pharmaceuticals is leveraging a novel continuous manufacturing platform called Integrated Continuous Manufacturing (ICM), initially developed through an $85 M joint research project between Novartis and MIT. In addition, the company is currently collaborating with hospital systems and pharmacy chains to establish its own generic business, where high-quality, low-cost drugs will be manufactured in the United States.